Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-000073-37Phase 4Completed
Phase 4, randomised trial of dopexamine, dobutamine, epinephrine and norepinephrine in None, mouth cancer and maxillofacial injuries (MFT) (4 arms), sponsored by Oxford University Hospitals. Primary endpoints: Optimal pharmacological agent for blood pressure maintenance, Absolute change in flap vascular resistance after pressor infusion and 1 more. Started Oct 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-000073-37.